DOJ Drops Motion Against Ranbaxy

Law360, New York (October 8, 2008, 12:00 AM EDT) -- After a war of words earlier this summer, the U.S. Department of Justice has taken a motion regarding the production of audit reports in an investigation of Indian pharmaceutical company Ranbaxy Laboratories Ltd. off the table.

On Wednesday, a Ranbaxy insider revealed that the DOJ had withdrawn its motion over audit documents connected to an ongoing investigation into the company's manufacturing practices.

"The U.S. Department of Justice has now been provided with a comprehensive set of audit documents based on instructions by Ranbaxy Laboratories, which will...
To view the full article, register now.